Luis de la Cruz, MD
Sleep Medicine · Spartanburg, SCNPI 1033138912
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $14,481 of the $19,903 with a category attached, or 72.8%. It is spread thinly across 50 manufacturers, the largest accounting for just 20.4%. Reporting peaked in 2024 at $6,234 and has fallen 69.7% since, to $1,891 in 2025. Among sleep medicine clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 735 payments — averaging $27.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$4K
- Astrazeneca UK Limited$2K
- GSK$2K
- Boehringer Ingelheim International GmbH$1K
- Inspire Medical Systems, Inc.$1K
- Boehringer Ingelheim$933
- plus $8K from 44 others
Across 5,012 payments — averaging $3527.89 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Modernatx, Inc.$10.3M
- Amgen$2.5M
- Eli Lilly$860K
- Merck$858K
- Boehringer Ingelheim$547K
- GSK$532K
- plus $2.1M from 22 others
What the payments were for
- Travel & lodging$5,06825%
- Food & beverage$14,48173%
- Education$3552%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BREZTRI$2,243
- BEVESPI AEROSPHERE$1,329
- Inspire$1,033
- FASENRA$255
- FloTrac Sensor$154
- FARXIGA$129
- TEZSPIRE$127
How this compares
$19,903 in reported general payments places this provider in the 95th percentile of 25 sleep medicine providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AdempasRiociguat | 12 | $169,323 |
| XyremSodium Oxybate | 11 | $155,139 |
| Dupixent PenDupilumab | 28 | $114,121 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 130 | $107,450 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 118 | $95,009 |
| TezspireTezepelumab-Ekko | 12 | $52,782 |
| Breo ElliptaFluticasone/Vilanterol | 71 | $36,711 |
| Spiriva RespimatTiotropium Bromide | 34 | $24,398 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 43 | $19,804 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 25 | $17,204 |
| Bevespi AerosphereGlycopyrrolate/Formoterol Fum | 26 | $12,555 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 437 | $10,714 |
| Incruse ElliptaUmeclidinium Bromide | 23 | $8,958 |
| SymbicortBudesonide/Formoterol Fumarate | 25 | $5,918 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 37 | $4,695 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Incruse Ellipta | $1,845 | $172,923267 claims |
| BayerAdempas | $76 | $169,32312 claims |
| AstraZenecaBreztri Aerosphere, Tezspire, Bevespi Aerosphere, Symbicort | $4,069 | $166,263181 claims |
| Boehringer IngelheimSpiriva Respimat, Stiolto Respimat | $933 | $41,60159 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 25 sleep medicine providers in South Carolina.
Other sleep medicine in Spartanburg
- Rupa KoothirezhiSpartanburg$4K
- William HollinsColumbia$147K
- Rodney HarrisonColumbia$14K
- Terry GraingerColumbia$10K
- Stephen HandAnderson$8K
- Fahd ZarroufAnderson$5K
- Robert PuchalskiLugoff$4K
- Jigme SethiCharlestib$4K
- Meher FarooqCharleston$3K
- Anam SabzwariConway$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.